Contact us

Search and Find the CMO / CDMO You Need

Discover highly skilled partners for your drug development and manufacturing project.

Showing 1 facilities
Suggested Results

These facilities match your main criteria but not every optional filter — including other countries in the same region.

Cenexi
France

Cenexi

Cenexi

GMP plant on a four-hectare site is located 9 km east of Paris. It is a center of excellence for injectable ampoules.

BATCH SIZE: Small, Medium, Large

CATEGORY / PRODUCT: FDF / DRUG PRODUCTS

MARKETS: EDE (UAE), ANVISA (Brazil), PMDA (Japan), FDA (USA), EMA (EU), MFDS (South Korea), TGA (Australia), NMPA (China), Health Canada (Canada), MHRA (UK)

COMPLIANCE: EMA (EU GMP), PMDA/MHLW (Japan GMP), ANVISA (Brazil B-GMP), FDA (cGMP), NMPA (China GMP), MFDS/KFDA (Republic of Korea GMP)

CONTROLLED SUBSTANCES: Lowest potential for abuse, High potential for abuse & no medical use, High potential for abuse & medical use, Lower potential for abuse, Low potential for abuse

REGION: Europe

USE: Human, Veterinary

SERVICES: Analytical / QC services, Logistics, Manufacturing services, Regulatory services, Development services, Packaging, Quality Assurance services

THERAPEUTIC AREAS OF EXPERTISE (ATC): (M) Musculoskeletal system, (L) Antineoplastic and immunomodulating agents, (J) Antiinfectives for systemic use, (C) Cardiovascular system, (A) Digestive tract and metabolism, (D) Dermatologicals, (N) Nervous system, (P) Antiparasitic products, insecticides and repellents

OEB (Occupational Exposure Banding): 1 / low-hazard (PDE > 10,000 µg/day)

Cenexi Hérouville Saint Clair
France

Cenexi Hérouville Saint Clair

Cenexi

The Hérouville-Saint-Clair site, located near Caen, in Normandy, specializes in the manufacture and filling of injectable and non-injectable sterile liquids.

BATCH SIZE: Small, Medium

CATEGORY / PRODUCT: FDF / DRUG PRODUCTS

COMPLIANCE: EMA (EU GMP), PMDA/MHLW (Japan GMP), ANVISA (Brazil B-GMP), MHRA (UK GMP), FDA (cGMP), NMPA (China GMP), MFDS/KFDA (Republic of Korea GMP)

CONTROLLED SUBSTANCES: Lowest potential for abuse, High potential for abuse & no medical use, High potential for abuse & medical use, Lower potential for abuse, Low potential for abuse

REGION: Europe

MARKETS: ANVISA (Brazil), PMDA (Japan), FDA (USA), Russian Health Authorities, EMA (EU), MFDS (South Korea), TGA (Australia), NMPA (China), MHRA (UK)

USE: Human

SERVICES: Analytical / QC services, Manufacturing services, Regulatory services, Packaging, Quality Assurance services

THERAPEUTIC AREAS OF EXPERTISE (ATC): (H) Systemic hormonal preparations excl. sex hormones and insulins, (J) Antiinfectives for systemic use, (C) Cardiovascular system, (A) Digestive tract and metabolism, (D) Dermatologicals, (N) Nervous system

OEB (Occupational Exposure Banding): 2 (PDE = 1,000 - 10,000 µg/day), 4 / HPAPI (PDE = 10 - 100 µg/day), 1 / low-hazard (PDE > 10,000 µg/day), 3 (PDE = 100 - 1,000 µg/day)

Limited view

PARTICLE ENGINEERING manufacturing site

MAI network supplier

An API and Interemediate manufacturer having global certifications.

Location available after registration

Limited view

SERVICES manufacturing site

MAI network supplier

R&D and GMP manufacturing site, Bowburn, Durham, UK

Location available after registration

Limited view

SERVICES manufacturing site

MAI network supplier

R&D Centre

Location available after registration

Limited view

FDF / DRUG PRODUCTS manufacturing site

MAI network supplier

Lannetts main manufacturing site sits in Seymour, Indiana, and includes capabilities for Oral Solid Dose (OSD) and Liquids.

Location available after registration

Limited view

CHEMICAL-SYNTHETIC manufacturing site

MAI network supplier

The CDMO company designs, develops, and manufactures new chemical entities to treat human disease.

Location available after registration

Limited view

FDF / DRUG PRODUCTS manufacturing site

MAI network supplier

Production facility that complies with the latest GMP standards for sterile and aseptic liquids, particularly glass ampoules.

Location available after registration

Limited view

BIOLOGICS manufacturing site

MAI network supplier

Process Development, Gene to Cell Line to GMP to Formulation Development, Analytical Development and Fill-Finish.

Location available after registration

Limited view

FDF / DRUG PRODUCTS manufacturing site

MAI network supplier

French CDMO key player in drug development and delivery of oral technologies serving the pharma and bio industries.

Location available after registration

Limited view

FDF / DRUG PRODUCTS manufacturing site

MAI network supplier

CDMO specialized in the manufacture and development of cosmetics,health products, insect repellents, anti-lice / head lice treatments and medical devices.

Location available after registration

Limited view

CHEMICAL-SYNTHETIC manufacturing site

MAI network supplier

Our 400+ team members in Charles City specialize in late-phase and commercial API development and cGMP manufacturing.

Location available after registration